Vanta Bioscience logo

Vanta Bioscience

VANTABIOSCIENCELTD NSE

Key Fundamentals

SMEHealthcare TechnologyHealthcare
Market Cap
₹14.60 Cr
Volatility
Moderate
P/E Ratio
137.2
EBITDA
₹1.02 Cr
Return on Equity
-351.27%
Debt to Equity
1.8
Book Value
₹29.77
EPS
₹0
52W High
₹29
52W Low
₹14.71

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has reduced debt.
  • Stock is trading at 0.69 times its book value

Weaknesses

6
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -28.6% over past five years.
  • Company has a low return on equity of -15.6% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 513 days.
  • Working capital days have increased from -636 days to 435 days

Growth Rate

Revenue Growth
-13.33% higher than 3Y
Net Income Growth
-100% lower than 3Y
Cash Flow Change
-190% higher than 3Y
ROE
430% higher than 3Y
ROCE
193% higher than 3Y
EBITDA Margin (Avg.)
-126% lower than 3Y

Quarterly Results

Particulars Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
6.81
5.28
4.76
5.38
4.31
2.82
3.45
6.18
3.55
1.03
0.33
0.3
1.51
Expenses
4.61
3.5
2.58
3.89
2.33
3.37
5.3
4.12
4.3
1.42
2.01
0.67
0.13
Operating Profit
2.2
1.78
2.18
1.49
1.98
-0.55
-1.85
2.06
-0.75
-0.39
-1.68
-0.37
1.38
OPM %
32.31%
33.71%
45.8%
27.7%
45.94%
-19.5%
-53.62%
33.33%
-21.13%
-37.86%
-509.09%
-123.33%
91.39%
Other Income
0.11
0
0.03
0.02
0.4
0.01
0.68
0.03
0.08
0.04
0.04
0
0.16
Interest
0.98
1.01
1.13
1.14
1.2
2.48
3.4
2.85
2.9
2.14
-0.06
0.88
-0.11
Depreciation
0.78
0.61
0.65
0.66
0.66
1.31
1.36
1.54
2.95
1.69
-0.17
0.61
-0.23
PBT
0.55
0.16
0.43
-0.29
0.52
-4.33
-5.93
-2.3
-6.52
-4.18
-1.41
-1.86
1.88
Tax %
16.36%
68.75%
9.3%
-106.9%
13.46%
2.08%
1.52%
-0.87%
-3.07%
-1.2%
-2.13%
-2.69%
-2.66%
Net Profit
0.46
0.06
0.39
0.02
0.07
-2.56
-3.92
-0.54
-1.78
-2.07
-1.37
-1.82
1.93
EPS in Rs
0.73
0.1
0.62
0.03
0.11
-4.06
-6.21
-0.86
-2.82
-3.28
-2.17
-2.56
2.71
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
12.08
13.75
9.82
9.4
5.83
9.72
1.96
1.82
Expenses
8.81
9.38
5.87
5.93
8.22
8.41
6.21
0.8
Operating Profit
3.27
4.37
3.95
3.47
-2.39
1.31
-4.25
1.02
OPM %
27.07%
31.78%
40.22%
36.91%
-40.99%
13.48%
-216.84%
56.04%
Other Income
0.23
0.11
0.03
0.42
0.69
0.11
0.11
0.16
Interest
1.69
1.95
2.14
2.35
5.89
5.75
4.07
0.78
Depreciation
0.71
1.19
1.25
1.32
2.67
4.5
4.42
0.39
PBT
1.1
1.34
0.59
0.22
-10.26
-8.83
-12.63
0.01
Tax %
36.36%
24.63%
23.73%
40.91%
1.75%
-2.49%
5.23%
-900%
Net Profit
0.7
1.01
0.45
0.14
-10.44
-8.61
-13.29
0.11
EPS in Rs
1.11
1.58
0.71
0.14
-10.27
-3.68
-7.56
0.15
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6.31
6.31
6.31
6.31
6.31
6.31
6.31
7.11
Reserves
15.94
17.16
17.61
17.7
11.2
8.89
4.11
14.06
Borrowings
13.25
17.37
35.97
44.86
57.16
60.96
70.09
38.08
Other Liabilities
3.51
7.74
9.74
12.53
10.04
9.24
5.37
6.85
Total Liabilities
39.01
48.58
69.63
81.4
84.71
85.4
85.88
66.1
Fixed Assets
17.9
20.76
29.39
36.12
57.22
54.15
55.5
48.08
CWIP
3.7
7
19.34
28.47
10.6
12.53
13.47
0
Investments
1.95
0
0
0
0
0
0
3
Other Assets
15.46
20.82
20.9
16.81
16.89
18.72
16.91
15.02
Total Assets
39.01
48.58
69.63
81.4
84.71
85.4
85.88
66.1
Figures in ₹ Crores

Cash Flow

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-1.04
2.34
6.97
5.28
-0.63
2.68
-2.41
-5.22
Investing
-5.73
-7.59
-22.3
-17.24
-5.91
-3.31
-6.69
-6.87
Financing
9.94
2.17
17.78
9.53
6.41
0.69
9.16
12.08
Net Cash Flow
3.18
-3.07
2.46
-2.43
-0.13
0.06
0.06
-0.01
Free Cash Flow
-3.52
-5.01
-15.23
-11.9
-6.54
-0.63
-9.1
-12.09
CFO/OP
-32
54
176
152
26
205
57
-512
Figures in ₹ Crores

Ratios

Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
47.14
36.9
74.71
43.88
123
118
466
513
Inventory Days
—
—
—
—
—
—
2,400
—
Days Payable
—
—
—
—
—
—
1,821
—
Cash Conversion Cycle
47.14
36.9
74.71
43.88
123
118
1,044
513
Working Capital Days
261
260
91.06
-135
-163
-217
-2,127
435
ROCE %
—
8.35%
5.21%
3.77%
-5.82%
-4.16%
-11.58%
1.19%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vanta Bioscience insights

57 extracted metrics + investor summaries across FY17–FY26.

Log in — free

Shareholding Pattern

Promot.72.81%Others2.68%Public24.51%As ofMar 2026

Documents

Frequently Asked Questions about Vanta Bioscience

What does Vanta Bioscience Ltd do?
Incorporated in 2016, Vanta Bioscience Ltd is a full-service preclinical contract research organisation. [1]
Where is Vanta Bioscience Ltd (540729) listed?
Vanta Bioscience Ltd trades as VANTABIOSCIENCELTD on the NSE and under code VANTABIO on the BSE.
Which sector does Vanta Bioscience Ltd belong to?
Vanta Bioscience Ltd is classified under the Healthcare sector, in the Healthcare Technology industry.
What is the market capitalisation of Vanta Bioscience Ltd?
Vanta Bioscience Ltd has a market capitalisation of ₹14.6 Cr, which places it in the Small Cap band.
What is the PE ratio of Vanta Bioscience Ltd?
Vanta Bioscience Ltd trades at a PE ratio of 137.20, on earnings per share of ₹0, against a book value of ₹29.77 per share.
What is the 52-week high and low of Vanta Bioscience Ltd?
Over the last 52 weeks Vanta Bioscience Ltd has traded between ₹14.71 and ₹29.
What is the Return on Equity (ROE) of Vanta Bioscience Ltd?
Vanta Bioscience Ltd reported a return on equity of -351.27%. Its debt-to-equity ratio is 1.80.

Company Information

Incorporated in 2016, Vanta Bioscience Ltd is a full-service preclinical contract research organisation. [1]

Website vantabio.com
Listed 2017-10-06
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540729.md for Vanta Bioscience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List